PrEP in the Headlines: Industry Moves That Matter
Let’s be real—when PrEP makes headlines, it’s not just news. It’s a vibe shift. And if you’re watching closely, 2025 has been serving major HIV prevention energy from every direction. So whether you’re deep in public health, writing for your readers, or just trying to stay ahead of the curve, here’s your cheat sheet to […]
Innovation Meets Empathy: Industry + People at the Center
Look, when it comes to HIV prevention, it’s easy to side-eye Big Pharma. But sometimes—just sometimes—they actually pull up for the people. And this? This is one of those moments. Because in the PrEP game, science is meeting soul. And for once, it’s not just about shiny press releases and market dominance—it’s about showing up […]
PrEP Help That Hits Different: Access Without the Headache
Let’s be honest—healthcare is a maze.Insurance? Confusing. Forms? Exhausting.Just trying to get protected? Overwhelming. But when it comes to PrEP, support should be easy.You shouldn’t need a translator or a policy decoder ring.And thanks to Gilead’s Advancing Access®, you don’t. 📞 Real Help, No Runaround Advancing Access isn’t just a “maybe we can help” kind […]
PrEP Isn’t Permission—It’s Power
Let’s clear something up real quick:Wanting protection doesn’t mean you’re doing the most.It means you’re doing what’s right—for you. 🗣️ Own It. Loudly. You don’t need a permission slip to take care of yourself. PrEP is not some backhanded moral test—it’s proof that you value your body, your peace of mind, and your joy. Whether […]
America’s Already In: Yeytuo Is the Future of PrEP
No need to look across the pond—the U.S. is already ahead of the curve. In June 2025, the FDA approved Yeztugo (lenacapavir) as the first-ever twice-yearly injectable PrEP in the country. That’s not just a win—it’s a game-changer for how we do HIV prevention in real life. This isn’t theory. It’s already happening. 🚦 What […]
Game On: Global PrEP Access Just Leveled Up
This isn’t a press release. This isn’t “coming soon.”This is global action—live and direct. For the first time ever, low- and middle-income countries (LMICs) are getting day-one access to a brand-new HIV prevention tool—not years later, not when the hype dies down, but right now. This is what equity in motion looks like. 🌍 Real […]
The PrEP Hustle: Access Is Yours—Let’s Get It
Barriers? Please. We build bridges around here. In HIV prevention, the problem isn’t just “is the med available?” It’s can you actually get it? That’s where the real hustle begins—and no, you’re not the only one who feels like the system is built to confuse you. Between insurance loops, copay traps, and eligibility riddles, it […]
The Price of Protection: Why PrEP Shouldn’t Break the Bank
Let’s keep it 100—PrEP isn’t a luxury item. It’s public health. It’s HIV prevention. It’s the kind of thing everyone should have access to, no questions asked. But with the launch of Yeztugo (aka lenacapavir), the shiny new twice-a-year injectable PrEP, we’re staring down a tough question:Who gets to stay protected—and who gets priced out? […]
Flip the Script: PrEP Isn’t About Judgment—It’s About You
When it comes to sexual health, too often the conversation is framed in whispers, stigma, and outdated ideas of morality. But it’s time to rewrite that script. PrEP—pre-exposure prophylaxis—isn’t about who you are or how you live. It’s about protecting yourself, taking control, and choosing what’s best for you. Reclaiming the Narrative In a world […]
Global PrEP Upgraded: WHO Backs Biannual Injections
In a landmark move for global public health, the World Health Organization (WHO) has officially endorsed lenacapavir—a twice-yearly injectable—as part of its HIV prevention toolkit. This recommendation marks a significant advancement in the fight against HIV, particularly for communities with the greatest need for accessible, long-acting prevention solutions. WHO’s Bold Stance On July 14, 2025, […]